Drug class
Non-nucleoside reverse-transcriptase inhibitor (NNRTI); antiretroviral
Mechanism of action
Binds directly and non-competitively to HIV-1 reverse transcriptase, blocking its activity and preventing viral replication.
General use cases
- HIV-1 pre-exposure prophylaxis in women through a 25 mg vaginal ring used as part of combination HIV-prevention approaches in settings where the ring is recommended and available
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
